Scattered Fat Invasion: An Indicator for Poor Prognosis in Premenopausal, and for Positive Estrogen Receptor in Postmenopausal Breast Cancer Patients

Publisher： Karger

E-ISSN： 1423-0232|59|1|25-30

ISSN： 0030-2414

Source： Oncology, Vol.59, Iss.1, 2000-11, pp. : 25-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FOXP3 Expression Is Related to High Ki-67 Index and Poor Prognosis in Lymph Node-Positive Breast Cancer Patients

By  

Oncology, Vol. 85, Iss. 2, 2013-08 ,pp. : 128-136

Karger

Access to resources Recommend Favorite

The Preoperative Neutrophil/Lymphocyte Ratio Does not Correlate with the 21-Gene Recurrence Score in Estrogen Receptor-Positive Breast Cancer Patients

By  

Oncology Research and Treatment, Vol. 38, Iss. 1-2, 2015-01 ,pp. : 24-27

Karger

Access to resources Recommend Favorite

Which Patients with Estrogen Receptor-Positive Early Breast Cancer Should Be Treated with Adjuvant Chemotherapy?

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 18-22

Karger

Access to resources Recommend Favorite

Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial (UCBG 0609)

By  

CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. : 3032-3040

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Risk Estrogen-Receptor-Positive Breast Cancer: Identification and Implications for Therapy

By Balleine Rosemary L.   Wilcken Nicholas R.  

Molecular Diagnosis & Therapy, Vol. 16, Iss. 4, 2012-08 ,pp. : 235-240

Adis International

Access to resources Recommend Favorite